Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TI... Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using our Co-Stimulatory Antigen Receptor, or CoStAR, platform. The company's lead product candidate, ITIL-168, is an autologous TIL therapy that it is initially developing for the treatment of PD-1-inhibitor relapsed or refractory advanced melanoma. Mehr anzeigen
Global registrational strategy in first-line non-squamous and squamous non-small cell lung cancer (NSCLC)Global registrational strategy in first-line triple-negative breast cancer (TNBC)Initiation...
In-licensed SYN-2510/IMM2510, a potentially best-in-class PD-L1xVEGF bispecific antibody, and SYN-27M/IMM27M, a next-generation ADCC-enhanced anti-CTLA-4 antibodyEntered into a 15-year lease for...
DALLAS and SHANGHAI, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL, “Instil”) and ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKEX Code: 1541.HK, “ImmuneOnco”), today...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -9.4529 | -18.0217261996 | 52.4528 | 55.19 | 32.855 | 238846 | 39.2101497 | CS |
| 4 | -7.0001 | -14.0002 | 50 | 92 | 32.855 | 499312 | 68.9242253 | CS |
| 12 | 30.4399 | 242.35589172 | 12.56 | 92 | 9.85 | 253164 | 56.19566878 | CS |
| 26 | 31.9899 | 290.553133515 | 11.01 | 92 | 9.62 | 126844 | 52.97065827 | CS |
| 52 | 35.0299 | 439.52195734 | 7.97 | 92 | 6.07 | 172856 | 24.22371793 | CS |
| 156 | -312.0001 | -87.8873521127 | 355 | 464.3 | 6.07 | 486294 | 81.54880691 | CS |
| 260 | -37.0001 | -46.250125 | 80 | 589.8 | 6.07 | 407224 | 116.02035513 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
